The activation of JNK is observed after global and focal cerebral ischemia (FCI) in rats and mice [17,18,19,20,21,22,23,24], and various small-molecule JNK inhibitors have exhibited neuroprotective effects in animal models, including stroke [25,26,27,28,29]. The gene discussed is MAPK8; the disease is Stroke.